scholarly journals Procedural Memory: Computer Learning in Control Subjects and in Parkinson’s Disease Patients

1996 ◽  
Vol 9 (3-4) ◽  
pp. 127-134
Author(s):  
C. Thomas-Antérion ◽  
B. Laurent ◽  
N. Foyatier-Michel ◽  
S. Laporte ◽  
D. Michel
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Procedural Memory ◽  
Control Group ◽  
Motor Tasks ◽  
Learning Session ◽  
Control Subjects ◽  
Student’S T ◽  
Better Than ◽  
Student’S T Test

We used perceptual motor tasks involving the learning of mouse control by looking at a Macintosh computer screen. We studied 90 control subjects aged between sixteen and seventy-five years. There was a significant time difference between the scales of age but improvement was the same for all subjects. We also studied 24 patients with Parkinson's disease (PD). We observed an influence of age and also of educational levels. The PD patients had difficulties of learning in all tests but they did not show differences in time when compared to the control group in the first learning session (Student's t-test). They learned two or four and a half times less well than the control group. In the first test, they had some difficulty in initiating the procedure and learned eight times less well than the control group. Performances seemed to be heterogeneous: patients with only tremor (seven) and patients without treatment (five) performed better than others but learned less. Success in procedural tasks for the PD group seemed to depend on the capacity to initiate the response and not on the development of an accurate strategy. Many questions still remain unanswered, and we have to study different kinds of implicit memory tasks to differentiate performance in control and basal ganglia groups.

scholarly journals Respiratory changes in Parkinson's disease may be unrelated to dopaminergic dysfunction

2012 ◽  
Vol 70 (11) ◽  
pp. 847-851 ◽  
Author(s):  
Luciana Ulhôa Guedes ◽  
Juliana Melo Rodrigues ◽  
Aline Andrioni Fernandes ◽  
Francisco E. Cardoso ◽  
Verônica Franco Parreira
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Statistical Analysis ◽  
Healthy Controls ◽  
Maximal Inspiratory Pressure ◽  
Age And Gender ◽  
Dopaminergic Dysfunction ◽  
And Gender ◽  
Student’S T ◽  
Student’S T Test

OBJECTIVE: To investigate the maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) in patients with Parkinson's disease (PD) during the on and off periods of levodopa and to compare with healthy controls. METHODS: Twenty-six patients were analyzed with Hoehn and Yahr scores (2-3) and 26 age and gender matched-controls. Statistical analysis was performed with Student's t-test for paired and independent samples. RESULTS: MIP and MEP values in patients were significantly lower than the values obtained in controls both for off and on stages -excepted for MIP in women (p=0.28). For patients with PD, the studied parameters did not differ between stages on and off, with the exception of MEP in women (p=0.00). CONCLUSIONS: Patients with PD have respiratory pressure lower than controls, even in early stages of the disease, and dopamine replacement has little impact over these respiratory pressures. These findings suggest that respiratory changes in PD may be unrelated to dopaminergic dysfunction.

scholarly journals A non-contact system for the assessment of hand motor tasks in people with Parkinson’s disease

2021 ◽  
Vol 3 (1) ◽  
Author(s):  
Fábio Henrique Monteiro Oliveira ◽  
Daniel Fernandes da Cunha ◽  
Amanda Gomes Rabelo ◽  
Luiza Maire David Luiz ◽  
Marcus Fraga Vieira ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Hand Movement ◽  
Electrical Potential ◽  
Body Part ◽  
The Body ◽  
Control Group ◽  
Motor Tasks ◽  
Micro Machine ◽  
Contact Sensors

AbstractClinical diagnosis of Parkinson’s disease (PD) motor symptoms remains a problem. Most of the current studies focus on objective evaluations to make the evaluation more reliable. Most of these systems are based on the use of inertial and electromyographic sensors that require contact with the body part being assessed. Contact sensors restrict natural movement, may be uncomfortable and may require preparation of the body, which may cause irritation. As an alternative to contact sensors for the study of hand motor tasks performed by subjects with and without PD, electrical potential sensing technology is used in this research. A custom hardware has been designed to enable data collection by hand movement. A micro-machine system validated the developed system, and a relationship model was established between hand displacement and non-contact capacitive (NCC) sensor response. An experiment was conducted, including 57 subjects, 30 with PD (experimental group) and 27 healthy control group, followed by an analysis of statistical features extracted from the instantaneous mean frequency (IMNF) of NCC sensor. These results were compared with those obtained from gyroscope signals that are considered in the field to be the gold standard. As a result, NCC responses were correlated linearly with hand displacement (R2 = 0.7692 and $${\text{R}}_{\text{adj}}^{2}$$ R adj 2  = 0.7631). The statistical evaluation of IMNF features showed, that both, contact and non-contact sensors, were able to discriminate movement patterns of the control group from the experimental one. The results confirm statistical similarity between features extracted from NCC and gyroscope signals.

scholarly journals Executive Functions in Parkinson’s Disease

Psico-USF ◽  
2021 ◽  
Vol 26 (3) ◽  
pp. 439-449
Author(s):  
Tainá Rossi ◽  
Mariane Bernardi Trevisol ◽  
Daiane Santos de Oliveira ◽  
Daiana Meregalli Schütz ◽  
Manuela Polidoro Lima ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Executive Functions ◽  
Processing Speed ◽  
Verbal Fluency ◽  
Control Group ◽  
Chi Square ◽  
Cross Sectional ◽  
Student’S T ◽  
And Control

Abstract The objective of this study was to investigate executive functions (EFs) in older adults with Parkinson’s disease (PD). It was a cross-sectional and comparative study, composed of 62 participants divided into PD group (n = 31; M age = 75.26; SD age = 7.26) and control group (n = 31; M age = 74.03; SD age = 6.95), aged 61 to 93 years, recruited for convenience in 5 cities in the state of Rio Grande do Sul. The instruments used were a sociodemographic data questionnaire; MMSE; GDS-15; BIS-11; verbal fluency tasks (FAS and animals), DEX; WCST-64 and FDT. Descriptive analyzes and Student’s t and Chi-square tests were used. The PD group had a lower performance in the WCST-64 and FDT tests compared to controls, indicating worse performance in tasks that required reasoning, cognitive flexibility and processing speed, in addition, showed difficulties in performing tasks that require EF (DEX).

scholarly journals Auditory Processing Abilities of Parkinson’s Disease Patients

2017 ◽  
Vol 2017 ◽  
pp. 1-10 ◽  
Author(s):  
Robert L. Folmer ◽  
Jay J. Vachhani ◽  
Sarah M. Theodoroff ◽  
Rachel Ellinger ◽  
Amy Riggins
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Hearing Loss ◽  
Auditory Processing ◽  
Study Groups ◽  
Control Group ◽  
Central Auditory Processing ◽  
Control Subjects ◽  
Age Related ◽  
Auditory Functions

Since Parkinson’s Disease (PD) primarily affects older people, a majority of PD patients have age-related hearing loss (HL) that will worsen over time. The goal of this study was to assess peripheral and central auditory functions in a population of PD patients and compare the results with a group of age-matched control subjects. Study participants included 35 adults with PD (mean age = 66.9 ± 11.2 years) and a group of 35 healthy control subjects (mean age = 65.4 ± 12.3 years). Assessments included questionnaires, neuropsychological tests, audiometric testing, and a battery of central auditory processing tests. Both study groups exhibited patterns of sensorineural hearing loss (slightly worse in the PD group) which were typical for their age and would contribute to difficulties in communication for many participants. Compared to the control group, PD patients reported greater difficulty in hearing words people are speaking. Although 27 PD patients (77%) were good candidates for amplification, only 7 (26%) of these hearing aid candidates used the devices. Because it is important for PD patients to optimize communication with their family members, caregivers, friends, and clinicians, it is vital to identify and remediate auditory dysfunction in this population as early as possible.

Differences in facial expression recognition between patients suffering from Parkinson's disease and healthy subjects

2011 ◽  
Vol 26 (S2) ◽  
pp. 1178-1178
Author(s):  
I. Laskowska ◽  
M. Wiłkość
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Facial Expressions ◽  
Control Group ◽  
Expression Recognition ◽  
Intelligence Scale ◽  
Control Subjects ◽  
Recognition Of Facial Expressions ◽  
Healthy Control ◽  
Male Subjects

IntroductionPatients with Parkinson's disease (PD) may show impairment in their ability to recognize facial expressions. It has been speculated that this deficit is linked to hypodopaminergic state which may be connected with an increase in amygdalic activity.ObjectivesThe objective of the study was to assess ability in the perception and recognition of facial expressions among thirty-eight PD subjects and thirty-eight healthy control subjects matched by age, sex, and education level.AimsTo investigate differences in perception of positive, negative and neutral facial expressions, such as sadness, happiness, anger, disgust, fear, astonishment, distrust, uncertainty, curiosity, satisfaction, tenderness, disbelief, embarrassment, disrespect.MethodsThe Polish Emotional Intelligence Scale - Faces (SIET) was used.ResultsThe results obtained indicate more deficits in recognition of sadness, anger, distrust, embarrassment and tenderness in PD subjects, while happiness was better recognized by PD subjects than by healthy control subjects. Overall, negative expressions were more poorly recognized by PD patients while there were no differences in recognition of positive and neutral emotions in both groups. In addition, astonishment, embarrassment and distrust were more poorly recognized in females with PD when compared with female control subjects. Whereas in male PD subjects, the recognition of disbelief and negative expressions was more impaired when compared with male subjects from the control group.ConclusionsThe results suggest that a hypodopaminergic state affects ability to recognize facial expressions, particularly those expressing negative emotions.

scholarly journals Upper Extremity Motor Learning among Individuals with Parkinson's Disease: A Meta-Analysis Evaluating Movement Time in Simple Tasks

2012 ◽  
Vol 2012 ◽  
pp. 1-7 ◽  
Author(s):  
K. Felix ◽  
K. Gain ◽  
E. Paiva ◽  
K. Whitney ◽  
M. E. Jenkins ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Motor Learning ◽  
Upper Extremity ◽  
Movement Time ◽  
Meta Analysis ◽  
Control Group ◽  
Motor Tasks ◽  
Reaching Tasks ◽  
Improved Performance

Motor learning has been found to occur in the rehabilitation of individuals with Parkinson's disease (PD). Through repetitive structured practice of motor tasks, individuals show improved performance, confirming that motor learning has probably taken place. Although a number of studies have been completed evaluating motor learning in people with PD, the sample sizes were small and the improvements were variable. The purpose of this meta-analysis was to determine the ability of people with PD to learn motor tasks. Studies which measured movement time in upper extremity reaching tasks and met the inclusion criteria were included in the analysis. Results of the meta-analysis indicated that people with PD and neurologically healthy controls both demonstrated motor learning, characterized by a decrease in movement time during upper extremity movements. Movement time improvements were greater in the control group than in individuals with PD. These results support the findings that the practice of upper extremity reaching tasks is beneficial in reducing movement time in persons with PD and has important implications for rehabilitation.

scholarly journals Study of cognitive impairment and genetic polymorphism of SLC41A1 (rs11240569 allele) in Parkinson’s disease in Upper Egypt: case-control study

2021 ◽  
Vol 57 (1) ◽  
Author(s):  
Hamdy N. El-Tallawy ◽  
Tahia H. Saleem ◽  
Wafaa M. Farghaly ◽  
Heba Mohamed Saad Eldien ◽  
Ashraf Khodaery ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Cognitive Impairment ◽  
Case Control Study ◽  
Case Control ◽  
Control Group ◽  
Motor Symptoms ◽  
And Control ◽  
Non Motor Symptoms ◽  
Control Study

Abstract Background Parkinson’s disease is one of the neurodegenerative disorders that is caused by genetic and environmental factors or interaction between them. Solute carrier family 41 member 1 within the PARK16 locus has been reported to be associated with Parkinson’s disease. Cognitive impairment is one of the non-motor symptoms that is considered a challenge in Parkinson’s disease patients. This study aimed to investigate the association of rs11240569 polymorphism; a synonymous coding variant in SLC41A1 in Parkinson’s disease patients in addition to the assessment of cognitive impairment in those patients. Results In a case -control study, rs11240569 single nucleotide polymorphisms in SLC41A1, genes were genotyped in 48 Parkinson’s disease patients and 48 controls. Motor and non-motor performance in Parkinson's disease patients were assessed by using the Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS). The genotype and allele frequencies were compared between the two groups and revealed no significant differences between case and control groups for rs11240569 in SLC41A1 gene with P value .523 and .54, respectively. Cognition was evaluated and showed the mean ± standard deviation (SD) of WAIS score of PD patients 80.4 ± 9.13 and the range was from 61 to 105, in addition to MMSE that showed mean ± SD 21.96 ± 3.8. Conclusion Genetic testing of the present study showed that rs11240569 polymorphism of SLC41A1 gene has no significant differences in distributions of alleles and genotypes between cases and control group, in addition to cognitive impairment that is present in a large proportion of PD patients and in addition to the strong correlation between cognitive impairment and motor and non-motor symptoms progression.

scholarly journals Donepezil for mild cognitive impairment in Parkinson’s disease

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Kyoungwon Baik ◽  
Seon Myeong Kim ◽  
Jin Ho Jung ◽  
Yang Hyun Lee ◽  
Seok Jong Chung ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Treatment Group ◽  
Outcome Measures ◽  
Rating Scale ◽  
Secondary Outcome ◽  
Control Group ◽  
Significant Difference

AbstractWe investigated the efficacy of donepezil for mild cognitive impairment in Parkinson’s disease (PD-MCI). This was a prospective, non-randomized, open-label, two-arm study. Eighty PD-MCI patients were assigned to either a treatment or control group. The treatment group received donepezil for 48 weeks. The primary outcome measures were the Korean version of Mini-Mental State Exam and Montreal Cognitive Assessment scores. Secondary outcome measures were the Clinical Dementia Rating, Unified Parkinson’s Disease Rating Scale part III, Clinical Global Impression scores. Progression of dementia was assessed at 48-week. Comprehensive neuropsychological tests and electroencephalography (EEG) were performed at baseline and after 48 weeks. The spectral power ratio of the theta to beta2 band (TB2R) in the electroencephalogram was analyzed. There was no significant difference in the primary and secondary outcome measures between the two groups. However, the treatment group showed a significant decrease in TB2R at bilateral frontotemporoparietal channels compared to the control group. Although we could not demonstrate improvements in the cognitive functions, donepezil treatment had a modulatory effect on the EEG in PD-MCI patients. EEG might be a sensitive biomarker for detecting changes in PD-MCI after donepezil treatment.

scholarly journals Limb and trunk accelerometer data collected with wearable sensors from subjects with Parkinson’s disease

2021 ◽  
Vol 8 (1) ◽  
Author(s):  
Gloria Vergara-Diaz ◽  
Jean-Francois Daneault ◽  
Federico Parisi ◽  
Chen Admati ◽  
Christina Alfonso ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Symptom Severity ◽  
Wearable Sensors ◽  
Motor Fluctuations ◽  
Sensor Data ◽  
Accelerometer Data ◽  
Motor Tasks ◽  
Specific Symptom ◽  
At Home

AbstractParkinson’s disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms. Dyskinesia and motor fluctuations are complications of PD medications. An objective measure of on/off time with/without dyskinesia has been sought for some time because it would facilitate the titration of medications. The objective of the dataset herein presented is to assess if wearable sensor data can be used to generate accurate estimates of limb-specific symptom severity. Nineteen subjects with PD experiencing motor fluctuations were asked to wear a total of five wearable sensors on both forearms and shanks, as well as on the lower back. Accelerometer data was collected for four days, including two laboratory visits lasting 3 to 4 hours each while the remainder of the time was spent at home and in the community. During the laboratory visits, subjects performed a battery of motor tasks while clinicians rated limb-specific symptom severity. At home, subjects were instructed to use a smartphone app that guided the periodic performance of a set of motor tasks.

scholarly journals Integrated network analysis identifying potential novel drug candidates and targets for Parkinson's disease

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Pusheng Quan ◽  
Kai Wang ◽  
Shi Yan ◽  
Shirong Wen ◽  
Chengqun Wei ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Drug Target ◽  
Target Genes ◽  
Enrichment Analysis ◽  
Gene Set Enrichment Analysis ◽  
Functional Enrichment ◽  
Control Group ◽  
Drug Candidates ◽  
Novel Drug

AbstractThis study aimed to identify potential novel drug candidates and targets for Parkinson’s disease. First, 970 genes that have been reported to be related to PD were collected from five databases, and functional enrichment analysis of these genes was conducted to investigate their potential mechanisms. Then, we collected drugs and related targets from DrugBank, narrowed the list by proximity scores and Inverted Gene Set Enrichment analysis of drug targets, and identified potential drug candidates for PD treatment. Finally, we compared the expression distribution of the candidate drug-target genes between the PD group and the control group in the public dataset with the largest sample size (GSE99039) in Gene Expression Omnibus. Ten drugs with an FDR < 0.1 and their corresponding targets were identified. Some target genes of the ten drugs significantly overlapped with PD-related genes or already known therapeutic targets for PD. Nine differentially expressed drug-target genes with p < 0.05 were screened. This work will facilitate further research into the possible efficacy of new drugs for PD and will provide valuable clues for drug design.

Sign in / Sign up

Export Citation Format

Share Document